Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
QuantumLeap Healthcare Collaborative
Centre Oscar Lambret
M.D. Anderson Cancer Center
AIDS Malignancy Consortium
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Amgen
M.D. Anderson Cancer Center
Leap Therapeutics, Inc.
National Cancer Institute (NCI)
GI Innovation, Inc.
Actuate Therapeutics Inc.
University of Oklahoma
Asan Medical Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Albert Einstein College of Medicine
Eastern Cooperative Oncology Group
Heidelberg University
University of Manchester
GOG Foundation
Asan Medical Center
AZ-VUB
GOG Foundation
Dong-A University Hospital
GOG Foundation
UNICANCER
City of Hope Medical Center
Amgen
GOG Foundation
National Cancer Institute (NCI)
GOG Foundation
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
NYU Langone Health
Fred Hutchinson Cancer Center
NIH AIDS Clinical Trials Information Service